Ampio says its study on Covid-19 patients proceeding to full open enrollment
Ampio Pharmaceuticals Inc has announced that its AP-014 Phase I inhaled Ampion clinical study in Covid-19 patients is proceeding to full open enrollment after...
Drawbridge Health ties up with University of Cambridge researchers
Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge announced the use of the OneDraw Blood Collection Device for remote...
Codagenix, Serum Institute of India start first-in-human trial of Covid-19 vaccine
Codagenix, Inc., and the Serum Institute of India Pvt. Ltd. (SIIPL) have announced that a Phase 1 clinical trial of COVI-VAC received regulatory approval...
Moderna to supply additional 2 mn doses of Covid-19 vaccine to United Kingdom
Moderna, Inc. has announced a supply agreement with the United Kingdom government for an additional 2 million doses of mRNA-1273,
Moderna is a biotechnology company...
Covid-19 investigational therapeutics to be analysed in big clinical trials
Covid-19 investigational therapeutics are to be evaluated in large clinical trials. Two controlled, randomized Phase 3 clinical trials have started evaluating investigational monoclonal antibodies...
Aspirin being tested as possible treatment for Covid-19
The humble Aspirin is all set to take on the mighty Covid-19. For, the commonly used medicine is being investigated in the world’s largest...
Lupus Research Awards 2023 announced
The Lupus Research Alliance (LRA) announced the recipients of the newest Lupus Innovation Award (LIA) grants.
Collectively, the seven projects led by research teams from the U.S. and Europe explore multiple...
Is immediate immunity against COVID-19 possible? Grifols starts clinical trial of new treatment
Grifols has announced it will begin a clinical trial in Spain to evaluate the safety and efficacy of a new COVID-19 immunity drug based...
Clues in human genome used by Scientists to find new inflammatory syndrome
Researchers attached to the National Institutes of Health (NIH) have found a new inflammatory disorder called vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome...
Postpartum depression may continue for 3 years after delivery
A new study has has found that approximately 1 in 4 experienced high levels of depressive symptoms at some point in the three years...
